These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30130968)

  • 1. Aggregation of Hydroxypropyl Methylcellulose Acetate Succinate under Its Dissolving pH and the Impact on Drug Supersaturation.
    Wang S; Liu C; Chen Y; Zhu AD; Qian F
    Mol Pharm; 2018 Oct; 15(10):4643-4653. PubMed ID: 30130968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using (1)H NMR technique.
    Ueda K; Higashi K; Yamamoto K; Moribe K
    Mol Pharm; 2015 Apr; 12(4):1096-104. PubMed ID: 25723893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-sensitivity HPLC-ELSD method for HPMC-AS quantification and its application in elucidating the release mechanism of HPMC-AS based amorphous solid dispersions.
    Wang S; Liu C; Chen Y; Zhang Z; Zhu A; Qian F
    Eur J Pharm Sci; 2018 Sep; 122():303-310. PubMed ID: 30006181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H; Handa T; Alonzo DE; Taylor LS
    Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
    Xie T; Gao W; Taylor LS
    Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.
    Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS
    Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Hydroxypropyl Methylcellulose Acetate Succinate Critical Aggregation Concentration on Celecoxib Supersaturation.
    Bristol AN; Lamm MS; Li Y
    Mol Pharm; 2021 Dec; 18(12):4299-4309. PubMed ID: 34738825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
    Butreddy A
    Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S; Kushida I; Yamashita T; Hasebe T; Shirai O; Kano K
    J Pharm Sci; 2013 Jul; 102(7):2273-81. PubMed ID: 23658029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of polymer-assisting supersaturation of poorly water-soluble loratadine based on experimental observations and molecular dynamic simulations.
    Zhang S; Sun M; Zhao Y; Song X; He Z; Wang J; Sun J
    Drug Deliv Transl Res; 2017 Oct; 7(5):738-749. PubMed ID: 28677032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and performance of hydroxypropyl methylcellulose esters of substituted succinates for in vitro supersaturation of a crystalline hydrophobic drug.
    Yin L; Hillmyer MA
    Mol Pharm; 2014 Jan; 11(1):175-85. PubMed ID: 24320108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution and precipitation behavior of amorphous solid dispersions.
    Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
    J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining ibuprofen sodium with cellulosic polymers: a deep dive into mechanisms of prolonged supersaturation.
    Terebetski JL; Michniak-Kohn B
    Int J Pharm; 2014 Nov; 475(1-2):536-46. PubMed ID: 25219860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.